{"nct_id":"NCT02910063","title":"Study to Evaluate Safety and Efficacy of Blinatumomab in Subjects With Relapsed/Refractory (R/R) Aggressive B-Cell NHL","status":"COMPLETED","status_verified_date":"2020-12","start_date":"2017-01-23","start_date_type":"ACTUAL","primary_completion_date":"2020-03-12","primary_completion_date_type":"ACTUAL","completion_date":"2020-03-12","completion_date_type":"ACTUAL","phases":["PHASE2","PHASE3"],"tickers":["AMGN"]}